YIELD10 BIOSCIENCE, INC.YTEN
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 21 | 15 | 8 | 20 | 12 | 7 | 14 | 3 | 5 | 3 | 5 | 2 |
---|
Short-term investments | - | - | - | - | - | - | - | 3 | 6 | 6 | 11 | 2 |
---|
Accounts receivable | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
---|
Unbilled receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Prepaid expenses and other current assets | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
---|
Total current assets | 78 | 49 | 25 | 22 | 15 | 8 | 15 | 6 | 12 | 10 | 17 | 5 |
---|
Restricted cash | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Property and equipment, net | 2 | 1 | 1 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
---|
Right-of-use assets | - | - | - | - | - | - | - | - | 3 | 3 | 2 | 2 |
---|
Other assets | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Total assets | 83 | 54 | 27 | 23 | 17 | 11 | 17 | 8 | 17 | 15 | 20 | 8 |
---|
Accounts payable | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Accrued expenses | 4 | 4 | 5 | 4 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
---|
Lease liabilities | - | - | - | - | - | - | - | - | 1 | 0 | 1 | 1 |
---|
Total current liabilities | 7 | 6 | 6 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
---|
Operating Lease, Liability, Noncurrent | - | - | - | - | - | - | - | - | 4 | 3 | 3 | 2 |
---|
Total liabilities | 43 | 6 | 6 | 4 | 4 | 4 | 3 | 2 | 21 | 5 | 4 | 4 |
---|
Preferred Stock, Value, Issued | - | - | - | - | - | - | 1 | - | - | - | - | - |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 285 | 289 | 293 | 320 | 339 | 340 | 355 | 358 | 361 | 385 | 402 | 404 |
---|
Accumulated other comprehensive loss | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
---|
Accumulated deficit | -246 | -242 | -273 | -302 | -326 | -333 | -343 | -352 | -365 | -375 | -386 | -400 |
---|
Total stockholders' equity | 39 | 47 | 20 | 19 | 13 | 6 | 14 | 6 | -4 | 10 | 16 | 4 |
---|
Total liabilities and stockholders' equity | 83 | 54 | 27 | 23 | 17 | 11 | 17 | 8 | 17 | 15 | 20 | 8 |
---|